
Vega Stem Cell Clinic
Location: Bangkok, Thailand
Vega Stem Cell Clinic offers specialized cellular administration programs, integrating modern laboratory purification with multi-specialty medical support for international patients.
Interest in regenerative medicine for neurological disorders has grown rapidly as standard treatment models face persistent clinical hurdles. Progressive neurological conditions such as Parkinson’s disease, spinal cord injuries, stroke, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries continue to create challenges for conventional medicine. Bangkok has emerged as a major destination for international patients seeking advanced stem cell protocols, combining specialized medical expertise, modern laboratory facilities, and dedicated international patient support. However, stem cell therapy remains an evolving field and must always be considered alongside direct neurologist evaluation and comprehensive evidence-based care.

| Key Aspect | Summary Details |
|---|---|
| Primary Target Conditions | Parkinson’s, Spinal Cord Injury (SCI), Stroke Recovery, MS, Alzheimer's/Dementia, TBI |
| Typical Cost Range | $10,000 – $25,000 USD (Varies by cell dosage, source, and hospital stay) |
| Average Treatment Stay | 7 to 14 days in Bangkok for administration and neuro-rehabilitation |
| Cell Sources Utilized | Umbilical Cord (UC-MSC), Bone Marrow (BM-MSC), Adipose (AD-MSC), Neural Stem Cells |
| Administration Routes | Intravenous (IV) Infusion, Intrathecal (IT) CSF Injection, or Combination Protocols |
| Primary Therapeutic Goals | Neuroinflammation control, neuroprotection, paracrine repair, functional support |
| Regulatory Status | Investigational/Supportive; non-curative and requires specialist supervision |
Neurological disorders represent one of the leading causes of disability and mortality worldwide. Conditions affecting the central nervous system frequently result in irreversible loss of physical function, cognitive decline, and chronic medical reliance.
To illustrate the magnitude of this challenge, the statistical infographic below details global prevalence and health burden numbers across major neurological diagnoses driving the need for supportive regenerative research.
Global Prevalence of Major Neurological Conditions (Millions of Cases Worldwide)
Global neurological disorders represent one of the leading causes of disability worldwide. Data source: World Health Organization (WHO) and Global Burden of Disease Study (IHME).
Traditional medical protocols for neurological conditions face significant limitations. Because many neurological diseases involve progressive, structural nerve cell damage, standard pharmaceuticals typically focus on symptom management rather than halting degeneration or restoring cellular structure.
As a result, patients are increasingly exploring regenerative medicine approaches designed to target underlying biochemical pathways:
Suppressing systemic and localized microglial neuroinflammation that accelerates nerve damage.
Releasing neurotrophic factors that protect surviving neurons and support synaptic plasticity.
Enhancing paracrine signaling mechanisms to stimulate natural tissue repair processes.
Combining biological therapy with targeted neuro-rehabilitation to improve daily recovery outcomes.
Medical tourism motivations also play a large role. International patients choose centers for Stem Cell Therapy for Neurological Disorders in Thailand to access specialized regenerative protocols, achieve lower total costs compared to Western private options, utilize comprehensive hospital infrastructure, and access immediate rehabilitation integration.
When selecting a treatment center for complex neurological evaluations, confirming physician credentials, laboratory certifications, and international patient care services is critical. Below are key accredited facilities in Bangkok:

Location: Bangkok, Thailand
Vega Stem Cell Clinic offers specialized cellular administration programs, integrating modern laboratory purification with multi-specialty medical support for international patients.

Location: Bangkok, Thailand
EDNA Wellness Anti-Aging & Regenerative Clinic provides tailored regenerative protocols focused on anti-inflammatory regulation, cellular therapies, and complete physical wellness care.
Mesenchymal stem cells (MSCs) and neural progenitor lines operate through multi-faceted physiological mechanisms rather than instantaneous organ replacement:
MSCs release anti-inflammatory cytokines that downregulate microglial overactivation, helping break chronic central nervous system inflammatory cycles.
By secreting neurotrophic growth factors like BDNF and NGF, stem cells create a protective shield around vulnerable and damaged neurons.
Through paracrine activity and extracellular vesicles (exosomes), cells send instructions to surrounding endogenous tissue to stimulate repair.
MSCs regulate autoimmune activity by balancing T-cell proliferation, which is particularly vital for conditions like Multiple Sclerosis.
Important Note: Stem cell therapy is not a guaranteed cure. Outcomes vary widely depending on disease type, progression stage, patient age, baseline physical condition, and adherence to long-term rehabilitation.
Research programs and clinical trials in Bangkok and globally evaluate stem cell applications across various neurological disorders:
Characterized by progressive loss of dopamine-producing neurons. Conventional medications manage motor symptoms temporarily. Regenerative approaches seek to reduce neuroinflammation, support dopaminergic neural circuits, and stabilize motor function.
Damage to spinal nerve tracts disrupts motor control and sensory processing. Clinical studies focus on using stem cells to reduce glial scar tissue formation, secrete supportive growth factors, and assist physical rehabilitation efforts.
Ischemic or hemorrhagic strokes cause rapid brain tissue necrosis. Stem cell applications aim to promote angiogenesis (new blood vessel growth), stimulate neuroplasticity, and enhance post-stroke functional recovery when paired with therapy.
An autoimmune condition where immune cells attack protective myelin sheaths. MSC protocols are investigated for their ability to reset dysregulated immune responses and encourage oligodendrocyte-mediated remyelination research.
Progressive cognitive decline driven by amyloid accumulation and neurofibrillary tangles. Research explores cellular signaling to clear neurotoxic inflammation, support vascular flow, and preserve cognitive function.
Physical impact creates acute and chronic cerebral swelling. Regenerative investigations focus on acute anti-inflammatory intervention and long-term neurovascular unit support to facilitate recovery.
Different cellular lineages offer distinct biochemical profiles, harvesting methods, and clinical focuses for central nervous system applications:
Stem Cell Source Comparison Matrix
| Stem Cell Type | Biological Source | Common Research Focus | Key Advantage |
|---|---|---|---|
| UC-MSC | Umbilical Cord Tissue | Immune modulation & anti-inflammatory signaling | High expansion rate, zero host harvesting pain |
| BM-MSC | Bone Marrow Aspiration | Autologous neuro-restorative applications | Long clinical history, patient's own tissue |
| AD-MSC | Adipose (Fat) Tissue | Vascular & tissue repair research | Abundant yield per harvest volume |
| Neural Stem Cells | Neural Tissue / iPSCs | Direct nervous system regeneration research | Targeted lineage commitment potential |
Different stem cell sources are studied for neurological applications, with mesenchymal stem cells among the most widely researched adult stem cell types. Source: ISSCR and NIH.
Before treatment approval, candidates undergo rigorous medical screening, including baseline neurological consultations, MRI/CT neuroimaging reviews, detailed blood panels, medical history verification, and standardized functional scale testing.
Depending on disease pathology and physician recommendations, cells are delivered through specialized routes:
Bangkok houses internationally accredited hospitals featuring modern 3T MRI systems, cleanroom cellular labs, and intensive care support teams.
Patients benefit from transparent pricing models that provide substantial cost savings compared to private Western experimental care.
Multilingual medical interpreters, airport VIP transfers, visa extension processing, and specialized long-stay family suites.
| Treatment Factor | Possible Cost Impact | Clinical Explanation |
|---|---|---|
| Stem Cell Source & Dosage | High Impact | Cell counts (e.g., 50M vs 200M+ MSCs) and laboratory culture depth directly alter processing expense. |
| Number of Sessions | Moderate to High Impact | Multiple intrathecal or IV administrations across a extended stay increase package fees. |
| Neuro-Rehabilitation | Moderate Impact | Inclusion of daily physical, occupational, robotics, or hyperbaric oxygen therapy (HBOT). |
| Hospital Stay & ICU Access | Variable Impact | Inpatient suite lodging versus outpatient clinical visits affects total billings. |
| Diagnostic Testing | Low to Moderate Impact | Pre- and post-treatment MRIs, EEGs, EMG studies, and extensive blood biomarker panels. |
*Disclaimer: Costs vary depending on diagnosis, individual protocol, cellular dosage, healthcare provider, and underlying medical requirements.
Patients and caregivers must understand that Regenerative Medicine for Neurological Disorders in Thailand does not guarantee complete neurological recovery. Results vary widely from minor stabilization to functional improvements. Continuous physical rehabilitation remains essential, and clinical trial evidence levels differ depending on the specific underlying neurological condition.
| Phase | Key Milestone | Patient Action & Clinical Process |
|---|---|---|
| 1. Before Traveling | Pre-Evaluation | Remote video consultation, submission of MRI/medical history, preliminary eligibility determination, treatment plan review. |
| 2. During Treatment | In-Clinic Care | Arrival in Bangkok, baseline diagnostic tests, specialist consultation, stem cell administration, monitoring, integrated rehabilitation. |
| 3. Returning Home | Long-Term Care | Telehealth consultations with medical coordinators, local physical therapy, ongoing neurological progress tracking. |
No, stem cell therapy is not a cure. It is an investigational biological approach aimed at reducing neuroinflammation, supporting tissue repair pathways, and enhancing recovery potential.
Clinical research focuses on conditions such as Parkinson’s disease, spinal cord injury, post-stroke recovery, multiple sclerosis, Alzheimer’s/dementia, and traumatic brain injury.
In most jurisdictions worldwide, adult stem cell treatments for neurological conditions remain investigational or are administered under specialized regenerative medicine frameworks.
Comprehensive treatment packages generally range from $10,000 to $25,000 USD, depending on cell dosage, delivery routes, and required hospital stay duration.
Most protocols require a stay of 7 to 14 days to allow for pre-procedure testing, stem cell administration, post-infusion monitoring, and initial rehabilitation.
Mesenchymal Stem Cells (MSCs)—sourced from umbilical cord tissue (UC-MSC), bone marrow (BM-MSC), or adipose tissue (AD-MSC)—are most commonly utilized.
When administered by qualified medical professionals using certified GMP laboratory cells, MSC therapies generally demonstrate a favorable safety profile with low rates of severe adverse events.
While direct cellular replacement is a long-term research goal, current therapeutic benefits rely mainly on paracrine signaling, growth factor release, and neuroinflammation suppression.
Yes. Combining biological cell therapies with active physical therapy, occupational therapy, and neuro-rehabilitation is strongly encouraged to maximize functional recovery.
Patients begin by submitting detailed medical records and recent neuroimaging for remote physician review, followed by a preliminary consultation to establish protocol candidacy.
Review accredited providers, compare physician credentials, inspect laboratory standards, and connect directly with international patient support coordinators.
Connect with PlacidWay ProvidersEducational Purpose: The information provided in this document is for educational and informational purposes only and does not constitute formal medical advice. Stem cell therapy for neurological disorders remains an evolving field. Always consult with qualified neurologists and medical specialists before undergoing international travel for medical treatments.
Share this listing